Cancer Center | Nicklaus Children's Hospital

Blood and Marrow Transplantation Program

The Blood and Marrow Transplantation Program at Nicklaus Children's Hospital is South Florida’s first and most experienced care provider for children requiring blood or bone marrow transplantation. Established in 1991, the program was originally accredited in 2003 by the Foundation for the Accreditation of Cellular Therapies (FACT) for all aspects of blood or marrow transplantation. The program continues to meet the rigorous FACT standards, having achieved its most recent reaccreditation in 2013. FACT accreditation is given to organizations that exceed standards in patient care and laboratory practices.

Expand the box below for a detailed list of conditions.

Excellent Outcomes Close to Home

The Blood and Marrow Transplant Program maintains outcomes that are the best in the region as reported by the National Marrow Donor Program (NMDP). The program’s experience and dedication to quality and in-depth staff training continues to drive outcomes that well exceed predicted outcomes.
 

Access to the Latest Research Protocols and Data

The Blood and Marrow Transplant Program is a Children’s Oncology Group (COG) accredited center for transplants and is a member of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) and the International Blood and Marrow Transplant Registry (IBMTR). Membership in these organizations brings access to the very latest research protocols and national and international research data. Nicklaus Children's Hospital has also been designated a Blue Distinction Center for Transplants in the category of pediatric blood and marrow transplantation . The hospital is also a FACT Accredited Transplant Center for blood and marrow transplants. 

Contact the Cancer Center
 305-662-8360


Service Locations

Nicklaus Children's Hospital Main Campus
3100 SW 62nd Avenue
Miami, FL 33155

Designated as a Blue Distinction Center for Transplants

 

Recognized by the American College of Surgeons Commission on Cancer

 

Accredited by the Foundation for the Accrediation of Cellular Therapies (FACT)